Add BrightSurf on Google Email

Does eczema increase the risk of developing shingles?

People with eczema face a higher risk of developing shingles due to an altered skin immune response. Researchers analyzed UK database data and found that eczema severity was directly linked to increased shingles risk.

SourceWiley·JournalJDDG Journal der Deutschen Dermatologischen Gesellschaft·DateAug 5, 2026

Scars of life: study shows impact of atopic dermatitis on educational and career choices

A novel study shows that adults with atopic dermatitis, particularly those with childhood onset, report significantly greater limitations in their educational and professional choices. The findings highlight the need for comprehensive, early, and multidimensional care to address the long-term impact of AD on life trajectories.

SourceElsevier·JournalJournal of Investigative Dermatology·TypeSurvey·DateMay 28, 2026

Here’s why your face doesn’t perceive itchiness the same way your body does

A new study reveals that facial itch sensations differ from those on the body due to distinct trigeminal and spinal pain pathways. The researchers found a functional divergence in neuropeptide signaling and central circuit engagement between the two systems, which was independent of peripheral innervation density.

SourceNorth Carolina State University·JournalCommunications Biology·TypeExperimental study·DateMay 4, 2026

Mount Sinai researchers identify unique coordination among cell types that support healthy human skin

Researchers created a comprehensive mapping of over 1 million cells in normal adult human skin, identifying 45 unique cell types that vary across composition and arrangement. This study brings scientists closer to developing more targeted treatments for skin diseases like eczema and psoriasis.

Major depressive disorder shares immune abnormalities and potential therapeutic targets with inflammatory skin diseases, according to new study

Researchers found that patients with major depressive disorder share immune abnormalities with inflammatory skin diseases, including atopic dermatitis. The study suggests targeting the Th2 pathway and interleukin-4 receptor alpha as potential therapeutic strategies for psychiatric illness.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalMolecular Psychiatry·TypeObservational study·DateFeb 11, 2026

Mount Sinai dermatologist reports Phase 3 success for rocatinlimab in moderate-to-severe eczema

Rocatinlimab shows durable improvements in skin clearance, itch, and quality of life by targeting OX40 immune receptor in patients with moderate-to-severe atopic dermatitis. The treatment led to significant reductions in eczema severity, itch, pain, and sleep disturbances.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateNov 25, 2025

New research links skin barrier dysfunction to pediatric eosinophilic esophagitis

A groundbreaking study suggests that the skin may serve as a biomarker for pediatric eosinophilic esophagitis (EoE), a chronic allergic disease of the esophagus. The study found significant deficits in ceramides, lipid molecules essential for the skin's protective barrier, in children with EoE but without atopic dermatitis.

SourceNational Jewish Health·JournalJournal of Allergy and Clinical Immunology·DateJun 6, 2025

Pet dogs could combat genetic eczema risk in children

Researchers found that exposure to dogs in early life reduced the risk of eczema in genetically predisposed children by suppressing skin inflammation. The study identified a genetic variant near an interleukin-7 receptor gene that responded differently to dog ownership, providing potential targets for future treatment or prevention.

SourceUniversity of Edinburgh·JournalAllergy·TypeObservational study·DateJun 4, 2025

Topical steroid withdrawal diagnostic criteria defined by NIH researchers

Researchers at NIH identified characteristic symptoms of topical steroid withdrawal (TSW), including elevated nicotinamide adenine dinucleotide (NAD+) levels, which can be diagnosed using provisional criteria. TSW treatment may involve mitochondrial complex I-blocking drugs, such as metformin or berberine.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalJournal of Investigative Dermatology·DateMar 14, 2025

Painful skin when tapering cortisone cream

A Swedish study found that topical steroid withdrawal (TSW) is characterized by symptoms such as redness, pain, and itching, often accompanied by sleep problems. The study aimed to understand the phenomenon of TSW, which many patients consider a cortisone dependence.

SourceUniversity of Gothenburg·JournalActa Dermato Venereologica·TypeSurvey·DateJan 14, 2025

Air pollution exposure may be associated with eczema

A new study published in PLOS ONE suggests that air pollution exposure may be associated with an increased risk of eczema. Data from hundreds of thousands of U.S. adults found that every 10-µm/m3 increase in PM2.5 levels doubles the eczema rate among residents.

SourcePLOS·JournalPLOS ONE·TypeObservational study·DateNov 13, 2024

CAMP 2.0 helps patients with contact dermatitis identify personal care products free of their allergens

The new CAMP 2.0 tool provides personalized medicine for managing allergic contact dermatitis by generating safe lists based on individual patch testing results. It offers thousands of product options and interactive tools to help patients find safe products, track their quality of life, and understand their allergens.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalDermatitis·TypeContent analysis·DateNov 12, 2024

Study: Parents’ understanding of atopic dermatitis may influence child’s diet

A survey of 298 parents with children diagnosed with atopic dermatitis found that parents' understanding of the condition and its dietary links significantly influenced their children's diets. The most frequently identified trigger foods were milk, tree nuts/seeds/peanuts, and eggs.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeSurvey·DateOct 24, 2024

Obese children are more likely to develop skin conditions related to the immune system

A large-scale study investigated the relationship between childhood obesity and immune-mediated skin diseases (IMSDs), such as atopic dermatitis and psoriasis. The study found that obese children were more likely to develop these conditions, with changes in body weight affecting their risk of developing these diseases.

SourceElsevier·JournalJournal of Investigative Dermatology·TypeData/statistical analysis·DateAug 21, 2024

New ACAAI position paper examines safety of receiving live vaccines while on dupilumab

The American College of Allergy, Asthma & Immunology (ACAAI) has issued a position paper on the safety of administering live vaccines to patients treated with dupilumab. The review suggests that treatment should not be stopped, but rather, shared decision-making between doctors and patients is recommended to weigh risks and benefits.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeLiterature review·DateJun 11, 2024

Unveiling the correlations between common triggers, comorbidities, and treatment approaches in Atopic Dermatitis patients

This nationwide study found that allergic rhinitis and hypertension are the most prevalent comorbidities among AD patients, while dietary triggers and seasonal changes exacerbate disease severity. The study also highlights the need for improved management strategies tackling these factors.

SourceBeijing Zhongke Journal Publising Co. Ltd.·JournalChinese Medical Journal·DateMay 30, 2024

Patient images are missing in studies on atopic dermatitis

A study from the University of Gothenburg found that patient images are severely lacking in scientific articles on atopic dermatitis. This lack of visual aids hinders patients' ability to make informed decisions about their care, as they struggle to understand complex medical terminology and figures. The absence of images also affects ...

SourceUniversity of Gothenburg·JournalJournal of Dermatological Treatment·TypeSystematic review·DateApr 9, 2024

How does climate change affect eczema?

A recent study published in Allergy found that climate change has negative effects on atopic dermatitis, including increased inflammation from air pollution and stress from droughts. The researchers called for further research to address the impact of multiple climatic factors on eczema incidence and prevalence.

SourceWiley·JournalAllergy·DateJan 24, 2024

New guidelines released for practitioners treating anaphylaxis and atopic dermatitis

The new guidelines offer evidence-based recommendations for diagnosing and managing anaphylaxis and atopic dermatitis in pediatric and adult patients. The guidelines emphasize the importance of patient values and preferences in arriving at optimal recommendations, reflecting advancements in diversity, equity, and inclusion.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeLiterature review·DateDec 18, 2023

Annals of Allergy, Asthma and Immunology examines effects of climate change on allergic conditions

A recent study published in Annals of Allergy, Asthma and Immunology examines the effects of climate change on various allergic conditions, including atopic dermatitis, asthma, and seasonal allergies. The research suggests that environmental warming can lead to longer-lasting pollen seasons and increased T2 inflammation.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·DateDec 13, 2023

New clues into the head-scratching mystery of itch

Researchers at Harvard Medical School have discovered a novel mechanism behind itch, revealing that Staphylococcus aureus single-handedly causes itch by instigating a molecular chain reaction. The study found that the bacterium's enzyme protease V8 activates protein PAR1 on skin neurons, leading to the sensation of itch.

SourceHarvard Medical School·JournalCell·TypeExperimental study·DateNov 22, 2023

Language barriers may cause some children to be underdiagnosed for allergic conditions

A study found that language difficulties lead to underdiagnosis of allergic conditions like asthma and eczema in children who speak a language other than English. A case report highlights the risks of pharmacy translation software interfering with prescription filling, causing delays in securing life-saving medications.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeContent analysis·DateNov 9, 2023

Skin and gut microbiome analysis offers new therapeutic perspectives on atopic dermatitis in Shiba Inu dogs

Researchers analyzed gut and skin microbiota in Shiba Inu dogs with atopic dermatitis, finding that treatment with Oclacitinib restored balance to the microbiome. The study suggests that microbes may serve as potential therapeutic targets for canine atopic dermatitis, offering new disease management strategies.

SourceUniversity of Lübeck·JournalMicrobiome·TypeExperimental study·DateOct 23, 2023

BNP peptide a culprit in eczema

The brain natriuretic peptide (BNP) is a peptide that plays a crucial role in activating atopic dermatitis, or eczema. In a mouse model of AD, mice without BNP exhibited reduced thickened skin and itching compared to control mice with BNP.

SourceNorth Carolina State University·JournalJournal of Investigative Dermatology·TypeRandomized controlled/clinical trial·DateOct 19, 2023

Clinical trial recommends methotrexate for children with severe atopic dermatitis

A clinical trial has shown that methotrexate is a useful and safe treatment for children with severe atopic dermatitis, offering better objective disease control compared to ciclosporin. The study found no concerning safety signals, making methotrexate an attractive alternative for patients in settings where healthcare resources are li...

SourceKing's College London·JournalBritish Journal of Dermatology·TypeRandomized controlled/clinical trial·DateSep 19, 2023

Inflammatory bowel disease linked to atopic dermatitis, Penn Medicine research finds

A new study from the University of Pennsylvania School of Medicine found a significant link between inflammatory bowel disease (IBD) and atopic dermatitis (AD), with adults having a 34% increased risk and children having a 44% increased risk. The severity of AD was also associated with an increased risk of developing IBD.

Study finds children who live close to highly trafficked roads have higher risk of developing atopic dermatitis

A recent study published by National Jewish Health has found that children who live close to highly trafficked roads are more likely to develop atopic dermatitis. The study, which analyzed data from 2008-2021, revealed that living within 500 meters of a highly trafficked road increased the risk of developing atopic dermatitis in children.

SourceNational Jewish Health·JournalJournal of Allergy and Clinical Immunology·TypeData/statistical analysis·DateJun 8, 2023